Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis
Status:
Withdrawn
Trial end date:
2019-02-06
Target enrollment:
Participant gender:
Summary
The primary objectives of this study are to investigate the efficacy and safety of topical
steroid ointment (clobetasol 0.05%) for the treatment of the cutaneous manifestations of
toxic epidermal necrolysis (TEN).